Effect of Normatec Pump for Relief of Leg Edema
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Hillel Yaffe Medical Center.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Hillel Yaffe Medical Center
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01112150
First received: April 12, 2010
Last updated: April 27, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators hypothesize that leg edema will decrease rapidly when using the NormaTec pump, patients will lose weight, will feel better, will be less prone to infections in their legs and to congestion of the liver. Temporary elevation of intravascular fluid volume by the mobilized edema fluid returned to the intravascular space by pumping may increase cardiac output and renal perfusion and in addition it may distend the right atrium and ventricle thus inducing BNP secretion. Both mechanisms may promote excess fluid removal by the kidneys.
| Condition | Intervention |
|---|---|
|
Edema Heart Failure Pulmonary Hypertension |
Device: NormaTec Pump |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Effect of Normatec Pump for Relief of Leg Edema: Short- Intermediate- and Longer-term Outcomes |
Resource links provided by NLM:
MedlinePlus related topics:
Edema
Heart Failure
High Blood Pressure
Pulmonary Hypertension
Weight Control
U.S. FDA Resources
Further study details as provided by Hillel Yaffe Medical Center:
Primary Outcome Measures:
- Weight Loss [ Time Frame: 5 days ] [ Designated as safety issue: No ]The weight loss during the pumping pariod is related to fluid loss from edematous legs.
Secondary Outcome Measures:
- Leg circumference [ Time Frame: 5 Days ] [ Designated as safety issue: No ]The leg circumference will be measured before and after each pumping session to determine the effectiveness of the pumping.
| Estimated Enrollment: | 20 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | July 2012 |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Pumping group
Patients in this arm will get a pumping session 2-3 times a day .
|
Device: NormaTec Pump
Normatec Pump
|
|
Active Comparator: No pumping
These patients will not receive pumping but only classical treatment clinically indicated (diuretics, oxygen, Digoxin, Nitrates, ACE inhibitors etc, as necessary)
|
Device: NormaTec Pump
Normatec Pump
|
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- hemodynamically stable adult patients with pronounced leg edema from any etiology, on optimal medical therapy (such as diuretics, ACE-I or ARBs, digoxin).
- documentation of right heart failure by Echo or other modality (CT, MRI, right heart catheterization) and hemodynamic data from Echo is required and an elevated pulmonary artery pressure (> 35 mmHg) is expected in such cases.
Exclusion Criteria:
- patients in sepsis,
- hemodynamically unstable,
- during an acute attack of pulmonary edema,
- with renal failure (creatinine > 2 mg%),
- with DVT,
- psychiatric or noncompliant patients, and
- patients who will not sign the informed consent form will be excluded from the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01112150
Contacts
| Contact: David S. Blondheim, MD | 97246304488 |
Locations
| Israel | |
| Hille Yaffe Medical Ceter | Recruiting |
| Hadera, Israel, 38100 | |
| Contact: David S Blondheim, MD 97246304488 | |
| Principal Investigator: David S. Blondheim, MD | |
Sponsors and Collaborators
Hillel Yaffe Medical Center
More Information
No publications provided
| Responsible Party: | David S. Blondheim, Hillel Yaffe Medical Center |
| ClinicalTrials.gov Identifier: | NCT01112150 History of Changes |
| Other Study ID Numbers: | 0063-09-HYMC-CTIL |
| Study First Received: | April 12, 2010 |
| Last Updated: | April 27, 2010 |
| Health Authority: | Israel: Ministry of Health |
Keywords provided by Hillel Yaffe Medical Center:
|
Edema Heart failure Pulmonary hypertension Edema in legs |
Additional relevant MeSH terms:
|
Edema Heart Failure Hypertension Hypertension, Pulmonary Signs and Symptoms |
Heart Diseases Cardiovascular Diseases Vascular Diseases Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 16, 2013